Results 151 to 160 of about 5,643 (237)

Table S6 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

open access: gold, 2023
Sriram Venneti   +83 more
openalex   +1 more source

DIPG-22. GENETIC MODELING IMPLICATES RAS AND MYC AS KEY EPIGENETICALLY ACTIVATED TRANSCRIPTIONAL TARGETS OF H3K27M-DRIVEN CANCER [PDF]

open access: bronze, 2019
Robert Siddaway   +6 more
openalex   +1 more source

Supplementary Figure from BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma

open access: gold, 2023
Eshini Panditharatna   +54 more
openalex   +1 more source

Diffuse midline gliomas, H3K27M-altered, of the pineal gland: the first synaptophysin-positive case and a systematic review. [PDF]

open access: yesRep Pract Oncol Radiother
Gaggero G   +8 more
europepmc   +1 more source

Table 1_PALB2 deficiency may sensitize H3K27M-mutant pediatric HGG cells to BMN673/talazoparib.xls

open access: green
Xiaowen Guan (6801044)   +3 more
openalex   +1 more source

New progress in the treatment of diffuse midline glioma with H3K27M alteration [PDF]

open access: gold
Zhi Yang   +4 more
openalex   +1 more source

Diffuse midline glioma with extra central nervous system metastases in the pediatric, adolescent, and young adult population. [PDF]

open access: yesChilds Nerv Syst
Giantini-Larsen AM   +10 more
europepmc   +1 more source

Table S8 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

open access: gold, 2023
Sriram Venneti   +83 more
openalex   +1 more source

Home - About - Disclaimer - Privacy